Customs simplified: the need to streamline pharma shipments
Pharmaceutical supply chains continue to be disrupted by a range of geopolitical factors, including global conflict, economic uncertainty, and especially…
All articles by
-
-
How 3PL providers are gearing up for the wave of cell and gene therapies
The global cell and gene therapy (CGT) market is expanding at a rapid rate, and will be worth $76bn by…
-
Overcoming cold-chain logistical challenges when delivering life-saving MS therapies
With the MS Trust estimating that more than 2.9 million people worldwide have multiple sclerosis (MS), new therapies are urgently…
-
Engineering the future: how robotics and automation are transforming pharmaceutical logistics
Maintaining efficiency across the supply chain is essential to ensure potentially life-saving pharmaceutical products reach the patients who need them.…
-
Oligonucleotides: The Scottish research hub accelerating production scale up
Oligonucleotides (oligos) are short strands of synthetic DNA or RNA that offer huge potential in treatments for a wide range…
-
End-to-end solutions: why every link in the pharmaceutical supply chain counts
Every stage of the pharmaceutical supply chain is critical if life-saving drugs are to make it to market – and…
-
How bioconjugation is unlocking the next generation of drug development
Bioconjugation creates new molecules with increased stability and improved targeting. The process of joining proteins, peptides, or oligonucleotides to synthetic…
-
Envirotainer expands cold chain solutions portfolio to cover all pharma segments, sizes and temperatures
Envirotainer, the specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain portfolio, enabling pharmaceutical companies to…
-
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The biosciences and healthcare industries are evolving rapidly, demanding innovative solutions and skilled professionals. Professor Vikki Rand, Director of Teesside…
-
The $100bn frontier: Untapped potential in animal health innovation
The global animal health market is a staggering $60bn industry, projected to reach $100bn by 2030. This phenomenal growth reflects…